Japan, Feb. 6 -- NOBELPHARMA CO LTD,TOKAI NATIONAL HIGHER EDUCATION & RESEARCH SYSTEM has got intellectual property rights for 'ZINC REPLACEMENT THERAPY AFTER BYPASS SURGERY.' Other related details are as follows:
Application Number: JP,2021-045312
Category (FI): A61K33/30,A61P3/12,A61P17/02,A61P9/00
Stage: Grant (IP right granted following substantive examination.)
Filing Date: March 19, 2021
Publication Date: Sept. 30, 2021
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....